Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

PARP1 and CBP lose their footing in cancer

The human histone macroH2A.1.1 recruits activated PARP1 enzyme to chromatin through its poly(ADP-ribose)-binding macrodomain. New work shows that PARP1 and CBP can be displaced from chromatin in cancer cells that have lost macroH2A.1.1, thus leading to changes in histone H2B acetylation at cancer-relevant genes.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Cancer cells usually lack the histone variant macroH2A.1.1; this leads to a decrease in gene expression–promoting histone acetylation (ac) at macroH2A.1-target genes.


  1. Hanahan, D. & Weinberg, R.A. Cell 144, 646–674 (2011).

    Article  CAS  Google Scholar 

  2. You, J.S. & Jones, P.A. Cancer Cell 22, 9–20 (2012).

    Article  CAS  Google Scholar 

  3. Filippakopoulos, P. & Knapp, S. Nat. Rev. Drug Discov. 13, 337–356 (2014).

    Article  CAS  Google Scholar 

  4. Maxmen, A. Nature 488, 148–150 (2012).

    Article  CAS  Google Scholar 

  5. Csankovszki, G., Panning, B., Bates, B., Pehrson, J.R. & Jaenisch, R. Nat. Genet. 22, 323–324 (1999).

    Article  CAS  Google Scholar 

  6. Pehrson, J.R. & Fried, V.A. Science 257, 1398–1400 (1992).

    Article  CAS  Google Scholar 

  7. Mermoud, J.E., Costanzi, C., Pehrson, J.R. & Brockdorff, N. J. Cell Biol. 147, 1399–1408 (1999).

    Article  CAS  Google Scholar 

  8. Sporn, J.C. et al. Oncogene 28, 3423–3428 (2009).

    Article  CAS  Google Scholar 

  9. Kapoor, A. et al. Nature 468, 1105–1109 (2010).

    Article  CAS  Google Scholar 

  10. Dardenne, E. et al. Nat. Struct. Mol. Biol. 19, 1139–1146 (2012).

    Article  CAS  Google Scholar 

  11. Kustatscher, G., Hothorn, M., Pugieux, C., Scheffzek, K. & Ladurner, A.G. Nat. Struct. Mol. Biol. 12, 624–625 (2005).

    Article  CAS  Google Scholar 

  12. Karras, G.I. et al. EMBO J. 24, 1911–1920 (2005).

    Article  CAS  Google Scholar 

  13. Langelier, M.F., Planck, J.L., Roy, S. & Pascal, J.M. Science 336, 728–732 (2012).

    Article  CAS  Google Scholar 

  14. Gibson, B.A. & Kraus, W.L. Nat. Rev. Mol. Cell Biol. 13, 411–424 (2012).

    Article  CAS  Google Scholar 

  15. Ali, A.A.E. et al. Nat. Struct. Mol. Biol. 19, 685–692 (2012).

    Article  CAS  Google Scholar 

  16. Timinszky, G. et al. Nat. Struct. Mol. Biol. 16, 923–929 (2009).

    Article  CAS  Google Scholar 

  17. Sporn, J.C. & Jung, B. Am. J. Pathol. 180, 2516–2526 (2012).

    Article  CAS  Google Scholar 

  18. Pasque, V., Gillich, A., Garrett, N. & Gurdon, J.B. EMBO J. 30, 2373–2387 (2011).

    Article  CAS  Google Scholar 

  19. Creppe, C. et al. Mol. Cell. Biol. 32, 1442–1452 (2012).

    Article  CAS  Google Scholar 

  20. Chen, H. et al. Nat. Struct. Mol. Biol. 21, 981–989 (2014).

    Article  CAS  Google Scholar 

Download references


We acknowledge support from the Deutsche Forschungsgemeinschaft to G.T. (TI817/2-1) and to A.G.L. (SFB1064 Chromatin Dynamics), and we thank C. Laverty for comments.

Author information

Authors and Affiliations


Corresponding author

Correspondence to Andreas G Ladurner.

Ethics declarations

Competing interests

Andreas Ladurner is on the Scientific Advisory Board of VolitionRx.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Timinszky, G., Ladurner, A. PARP1 and CBP lose their footing in cancer. Nat Struct Mol Biol 21, 947–948 (2014).

Download citation

  • Published:

  • Issue Date:

  • DOI:


Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer